Related Experiment Video
Updated: Mar 3, 2026

07:58
Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
Published on: May 30, 2017
11.6K
Repurposing a Two-Component System-Based Biosensor for the Killing of Vibrio cholerae.
Premkumar Jayaraman1,2, Maciej B Holowko3, Jing Wui Yeoh1,2
1Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore , Singapore.
ACS Synthetic Biology
|April 26, 2017
Summary
Scientists engineered Escherichia coli to detect and kill Vibrio cholerae, the cause of cholera. This synthetic biology approach offers a potential new probiotic treatment for cholera prevention and therapy.
Area of Science:
- Synthetic biology
- Microbiology
- Molecular biology
Background:
- Cholera remains a significant global health threat requiring novel control strategies.
- Current treatments for cholera are limited, necessitating innovative therapeutic approaches.
- Targeting the causative agent, Vibrio cholerae, is crucial for effective cholera management.
Purpose of the Study:
- To develop and validate an in vitro sense-and-kill system using engineered Escherichia coli to combat Vibrio cholerae.
- To create a synthetic biology-based approach for detecting and eliminating V. cholerae.
- To lay the groundwork for a potential probiotic treatment for cholera.
Main Methods:
- Engineered a wild-type Escherichia coli strain with a synthetic biology sense-and-kill system.
- Utilized V. cholerae's quorum-sensing molecule CAI-1 for specific pathogen detection.
- Incorporated lysis protein YebF-Art-085 and killing protein Art-085 for targeted V. cholerae elimination.
- Characterized protein expression and activity within a V. cholerae biosensing circuit.
Main Results:
- The engineered E. coli successfully detected V. cholerae via CAI-1.
- The system demonstrated self-lysis of E. coli to release Art-085 for V. cholerae killing.
- In the presence of V. cholerae supernatant, the integrated system effectively inhibited V. cholerae growth.
- Individual components YebF-Art-085 and Art-085 showed expected expression and activity.
Conclusions:
- The developed sense-and-kill system represents a proof-of-concept for targeting V. cholerae.
- This synthetic biology approach shows promise for a novel probiotic cholera treatment.
- Further development could lead to future preventative and therapeutic strategies for cholera.

